265 related articles for article (PubMed ID: 26150344)
41. Maturation of human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) on polycaprolactone and polyurethane nanofibrous mats.
Iwoń Z; Krogulec E; Tarnowska I; Łopianiak I; Wojasiński M; Dobrzyń A; Jastrzębska E
Sci Rep; 2024 Jun; 14(1):12975. PubMed ID: 38839879
[TBL] [Abstract][Full Text] [Related]
42. Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment.
Huang CY; Peres Moreno Maia-Joca R; Ong CS; Wilson I; DiSilvestre D; Tomaselli GF; Reich DH
J Mol Cell Cardiol; 2020 Jan; 138():1-11. PubMed ID: 31655038
[TBL] [Abstract][Full Text] [Related]
43. The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.
Masumoto H; Nakane T; Tinney JP; Yuan F; Ye F; Kowalski WJ; Minakata K; Sakata R; Yamashita JK; Keller BB
Sci Rep; 2016 Jul; 6():29933. PubMed ID: 27435115
[TBL] [Abstract][Full Text] [Related]
44. Single-Cell Transcriptomics of Engineered Cardiac Tissues From Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Abnormal Developmental Trajectory and Intrinsic Contractile Defects in Hypoplastic Right Heart Syndrome.
Lam YY; Keung W; Chan CH; Geng L; Wong N; Brenière-Letuffe D; Li RA; Cheung YF
J Am Heart Assoc; 2020 Oct; 9(20):e016528. PubMed ID: 33059525
[TBL] [Abstract][Full Text] [Related]
45. Protocol for Morphological and Functional Phenotype Analysis of hiPS-Derived Cardiomyocytes.
Li J; Lee JK
Methods Mol Biol; 2021; 2320():91-100. PubMed ID: 34302651
[TBL] [Abstract][Full Text] [Related]
46. Creation of human cardiac cell sheets using pluripotent stem cells.
Matsuura K; Wada M; Shimizu T; Haraguchi Y; Sato F; Sugiyama K; Konishi K; Shiba Y; Ichikawa H; Tachibana A; Ikeda U; Yamato M; Hagiwara N; Okano T
Biochem Biophys Res Commun; 2012 Aug; 425(2):321-7. PubMed ID: 22842572
[TBL] [Abstract][Full Text] [Related]
47. Effect of stem cell niche elasticity/ECM protein on the self-beating cardiomyocyte differentiation of induced pluripotent stem (iPS) cells at different stages.
Hirata M; Yamaoka T
Acta Biomater; 2018 Jan; 65():44-52. PubMed ID: 29066419
[TBL] [Abstract][Full Text] [Related]
48. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
Parveen S; Singh SP; Panicker MM; Gupta PK
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
[TBL] [Abstract][Full Text] [Related]
49. Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration.
Masumoto H; Ikuno T; Takeda M; Fukushima H; Marui A; Katayama S; Shimizu T; Ikeda T; Okano T; Sakata R; Yamashita JK
Sci Rep; 2014 Oct; 4():6716. PubMed ID: 25336194
[TBL] [Abstract][Full Text] [Related]
50. A Method for Contraction Force Measurement of hiPSC-Derived Engineered Cardiac Tissues.
Fujiwara Y; Deguchi K; Miki K; Nishimoto T; Yoshida Y
Methods Mol Biol; 2021; 2320():171-180. PubMed ID: 34302658
[TBL] [Abstract][Full Text] [Related]
51. Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells.
James EC; Tomaskovic-Crook E; Crook JM
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809429
[TBL] [Abstract][Full Text] [Related]
52. Stromal Cells in Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue.
Roberts MA; Tran D; Coulombe KL; Razumova M; Regnier M; Murry CE; Zheng Y
Tissue Eng Part A; 2016 Apr; 22(7-8):633-44. PubMed ID: 26955856
[TBL] [Abstract][Full Text] [Related]
53. Channelled scaffolds for engineering myocardium with mechanical stimulation.
Zhang T; Wan LQ; Xiong Z; Marsano A; Maidhof R; Park M; Yan Y; Vunjak-Novakovic G
J Tissue Eng Regen Med; 2012 Oct; 6(9):748-56. PubMed ID: 22081518
[TBL] [Abstract][Full Text] [Related]
54. Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted Myocardium.
Li J; Minami I; Shiozaki M; Yu L; Yajima S; Miyagawa S; Shiba Y; Morone N; Fukushima S; Yoshioka M; Li S; Qiao J; Li X; Wang L; Kotera H; Nakatsuji N; Sawa Y; Chen Y; Liu L
Stem Cell Reports; 2017 Nov; 9(5):1546-1559. PubMed ID: 29107590
[TBL] [Abstract][Full Text] [Related]
55. Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.
Tan Y; Richards D; Xu R; Stewart-Clark S; Mani SK; Borg TK; Menick DR; Tian B; Mei Y
Nano Lett; 2015 May; 15(5):2765-72. PubMed ID: 25826336
[TBL] [Abstract][Full Text] [Related]
56. Building a Total Bioartificial Heart: Harnessing Nature to Overcome the Current Hurdles.
Taylor DA; Frazier OH; Elgalad A; Hochman-Mendez C; Sampaio LC
Artif Organs; 2018 Oct; 42(10):970-982. PubMed ID: 30044011
[TBL] [Abstract][Full Text] [Related]
57. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
58. Cell Sheet-Based Vascularized Myocardial Tissue Fabrication.
Komae H; Ono M; Shimizu T
Eur Surg Res; 2018; 59(3-4):276-285. PubMed ID: 30244251
[TBL] [Abstract][Full Text] [Related]
59. Fabrication of electrospun poly (lactide-co-glycolide)-fibrin multiscale scaffold for myocardial regeneration in vitro.
Sreerekha PR; Menon D; Nair SV; Chennazhi KP
Tissue Eng Part A; 2013 Apr; 19(7-8):849-59. PubMed ID: 23083104
[TBL] [Abstract][Full Text] [Related]
60. Contractile Force Measurement of Engineered Cardiac Tissues Derived from Human iPS Cells.
Sasaki D; Matsuura K; Shimizu T
Methods Mol Biol; 2021; 2320():161-170. PubMed ID: 34302657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
